Published in Cancer Weekly, November 19th, 2002
Sponsored by Medtronic, Inc., (MDT) the study showed that opioids delivered through an implantable infusion system provided better relief from moderate to severe cancer pain with smaller doses and significantly fewer side effects than standard treatments (like pills, patches and shots) alone. Intrathecal infusion - delivery of medication directly into the fluid surrounding the spinal cord, where nerve cells that regulate pain are located -...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.